LINK WILLIAM J PHD
SEC CIK 1228684 · EDGAR
BoughtSold
Most active insiders at TARS, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Azamian Bobak R. | Pres, CEO, Board COB, Dir | — | $5.51M |
| 2 | LINK WILLIAM J PHD | Dir | — | $4.48M |
| 3 | Whitfield Dianne C. | CHRO | — | $2.69M |
| 4 | Lin Elizabeth Yeu | Chief Medical Off | — | $2.36M |
| 5 | Neervannan Seshadri | COO | — | $2.00M |
| 6 | Farrow Jeffrey S | See Remarks | — | $1.32M |
| 7 | Mottiwala Aziz | Chief Commercial Off | — | $892.5K |
| 8 | Wahl Bryan | GC | — | $850.4K |
| 9 | Goodrich Katherine | Dir | — | $183.4K |
| 10 | Goldberg Andrew D. | Dir | — | — |
Transactions 45
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2026-09-17 16:22 | 2026-09-15 | TARS | Tarsus Pharmaceuticals, Inc. | LINK WILLIAM J PHD | Dir | M - OptEx | — | +201 | 107.0K | +0.2% | — |
| DMT | 2026-09-17 16:22 | 2026-09-15 | TARS | Tarsus Pharmaceuticals, Inc. | LINK WILLIAM J PHD | Dir | S - Sale+OE | $78.38 | -12.5K | 94.5K | -12% | -$979.7K |
| 2026-06-18 16:08 | 2026-06-17 | RXST | RxSight, Inc. | LINK WILLIAM J PHD | Dir | A - Grant | — | +37.0K | 74.9K | +98% | — | |
| MT | 2026-06-17 16:17 | 2026-06-15 | TARS | Tarsus Pharmaceuticals, Inc. | LINK WILLIAM J PHD | Dir | S - Sale | $62.12 | -12.5K | 106.8K | -10% | -$776.5K |
| D | 2026-06-16 16:06 | 2026-06-12 | TARS | Tarsus Pharmaceuticals, Inc. | LINK WILLIAM J PHD | Dir | M - OptEx | — | +2,954 | 119.3K | +3% | — |
| 2026-06-05 17:30 | 2026-06-03 | LNSR | LENSAR, Inc. | LINK WILLIAM J PHD | Dir | A - Grant | $0.00 | +17.4K | 568.1K | +3% | $0 | |
| M | 2026-03-18 | 2026-03-16 | TARS | Tarsus Pharmaceuticals, Inc. | LINK WILLIAM J PHD | Dir | S - Sale | $68.79 | -12.5K | 125.2K | -9% | -$859.8K |
| M | 2025-12-17 | 2025-12-15 | TARS | Tarsus Pharmaceuticals, Inc. | LINK WILLIAM J PHD | Dir | S - Sale | $81.43 | -12.5K | 130.0K | -9% | -$1.02M |
| MI | 2025-12-17 | 2025-12-15 | TARS | Tarsus Pharmaceuticals, Inc. | LINK WILLIAM J PHD | Dir | S - Sale | $81.07 | -10.4K | 0 | -100% | -$846.9K |
| 2025-09-18 | 2025-09-16 | TARS | Tarsus Pharmaceuticals, Inc. | LINK WILLIAM J PHD | Dir | G - Gift | $0.00 | -2,000 | 141.3K | -1% | $0 | |
| 2025-09-10 | 2025-09-08 | TARS | Tarsus Pharmaceuticals, Inc. | LINK WILLIAM J PHD | Dir | S - Sale | $57.00 | -27.1K | 143.3K | -16% | -$1.55M | |
| D | 2025-06-16 | 2025-06-13 | TARS | Tarsus Pharmaceuticals, Inc. | LINK WILLIAM J PHD | Dir | M - OptEx | — | +3,350 | 170.4K | +2% | — |
| 2025-06-04 | 2025-06-03 | RXST | RxSight, Inc. | LINK WILLIAM J PHD | Dir | A - Grant | — | +10.8K | 37.9K | +40% | — | |
| 2025-05-28 | 2025-05-23 | LNSR | LENSAR, Inc. | LINK WILLIAM J PHD | Dir | A - Grant | $0.00 | +7,374 | 550.6K | +1% | $0 | |
| MI | 2024-08-14 | 2024-08-12 | TARS | Tarsus Pharmaceuticals, Inc. | LINK WILLIAM J PHD | Dir | S - Sale | $26.08 | -35.0K | 0 | -100% | -$913.0K |
| MI | 2024-08-14 | 2024-08-12 | TARS | Tarsus Pharmaceuticals, Inc. | LINK WILLIAM J PHD | Dir | J - Other | $0.00 | -64.4K | 35.0K | -65% | $0 |
| 2024-08-14 | 2024-08-12 | TARS | Tarsus Pharmaceuticals, Inc. | LINK WILLIAM J PHD | Dir | J - Other | $0.00 | +27.1K | 167.1K | +19% | $0 | |
| D | 2024-06-25 | 2024-06-24 | TARS | Tarsus Pharmaceuticals, Inc. | LINK WILLIAM J PHD | Dir | M - OptEx | — | +3,350 | 140.0K | +2% | — |
| 2024-06-10 | 2024-06-06 | RXST | RxSight, Inc. | LINK WILLIAM J PHD | Dir | A - Grant | — | +2,554 | 27.1K | +10% | — | |
| 2024-05-09 | 2024-05-07 | LNSR | LENSAR, Inc. | LINK WILLIAM J PHD | Dir | A - Grant | $0.00 | +22.0K | 543.3K | +4% | $0 | |
| MI | 2024-02-02 | 2024-02-01 | RXST | RxSight, Inc. | LINK WILLIAM J PHD | Dir | S - Sale | $49.67 | -28.2K | 31.9K | -47% | -$1.40M |
| I | 2024-02-02 | 2024-02-01 | RXST | RxSight, Inc. | LINK WILLIAM J PHD | Dir | G - Gift | $0.00 | -3,000 | 21.2K | -12% | $0 |
| MI | 2023-08-18 | 2023-08-17 | RXST | RxSight, Inc. | LINK WILLIAM J PHD | Dir | J - Other | $0.00 | -672.9K | 0 | -100% | $0 |
| 2023-08-18 | 2023-08-17 | RXST | RxSight, Inc. | LINK WILLIAM J PHD | Dir | J - Other | $0.00 | +2,610 | 24.5K | +12% | $0 | |
| D | 2023-06-21 | 2023-06-16 | TARS | Tarsus Pharmaceuticals, Inc. | LINK WILLIAM J PHD | Dir | M - OptEx | — | +2,000 | 136.6K | +1% | — |
| 2023-06-05 | 2023-06-01 | RXST | RxSight, Inc. | LINK WILLIAM J PHD | Dir | A - Grant | $0.00 | +5,731 | 21.9K | +35% | $0 | |
| D | 2023-05-30 | 2023-05-25 | LNSR | LENSAR, Inc. | LINK WILLIAM J PHD | Dir | A - Grant | $0.00 | +9,288 | 521.3K | +2% | $0 |
| MI | 2023-05-15 | 2023-05-11 | TARS | Tarsus Pharmaceuticals, Inc. | LINK WILLIAM J PHD | Dir | J - Other | $0.00 | -174.4K | 109.9K | -61% | $0 |
| MI | 2023-05-12 | 2023-05-11 | RXST | RxSight, Inc. | LINK WILLIAM J PHD | Dir | J - Other | $0.00 | -159.7K | 0 | -100% | $0 |
| MI | 2023-03-17 | 2023-03-15 | TARS | Tarsus Pharmaceuticals, Inc. | LINK WILLIAM J PHD | Dir | J - Other | $0.00 | -163.4K | 68.7K | -70% | $0 |
| MI | 2022-11-14 | 2022-11-10 | TARS | Tarsus Pharmaceuticals, Inc. | LINK WILLIAM J PHD | Dir | J - Other | $0.00 | -207.2K | 16.5K | -93% | $0 |
| MI | 2022-11-14 | 2022-11-09 | RXST | RxSight, Inc. | LINK WILLIAM J PHD | Dir | J - Other | $0.00 | -209.5K | 258.4K | -45% | $0 |
| MI | 2022-08-17 | 2022-08-15 | TARS | Tarsus Pharmaceuticals, Inc. | LINK WILLIAM J PHD | Dir | J - Other | $0.00 | -211.8K | 646.7K | -25% | $0 |
| MI | 2022-08-11 | 2022-08-10 | RXST | RxSight, Inc. | LINK WILLIAM J PHD | Dir | J - Other | $0.00 | -209.5K | 488.2K | -30% | $0 |
| MI | 2022-06-09 | 2022-06-08 | RXST | RxSight, Inc. | LINK WILLIAM J PHD | Dir | J - Other | $0.00 | -248.0K | 891.8K | -22% | $0 |
| AI | 2022-06-08 | 2022-05-17 | RXST | RxSight, Inc. | LINK WILLIAM J PHD | Dir | J - Other | $0.00 | +127.0K | 254.0K | +100% | $0 |
| AI | 2022-06-08 | 2022-03-15 | RXST | RxSight, Inc. | LINK WILLIAM J PHD | Dir | J - Other | $0.00 | +127.0K | 127.0K | New | $0 |
| 2022-06-03 | 2022-06-02 | RXST | RxSight, Inc. | LINK WILLIAM J PHD | Dir | A - Grant | $0.00 | +10.3K | 47.5K | +28% | $0 | |
| D | 2022-05-31 | 2022-05-25 | LNSR | LENSAR, Inc. | LINK WILLIAM J PHD | Dir | A - Grant | $0.00 | +4,285 | 512.0K | +0.8% | $0 |
| I | 2022-05-19 | 2022-05-17 | RXST | RxSight, Inc. | LINK WILLIAM J PHD | Dir | J - Other | $0.00 | -375.0K | 1.27M | -23% | $0 |
| I | 2022-03-17 | 2022-03-15 | RXST | RxSight, Inc. | LINK WILLIAM J PHD | Dir | J - Other | $0.00 | -375.0K | 1.64M | -19% | $0 |
| MI | 2021-11-16 | 2021-11-11 | TARS | Tarsus Pharmaceuticals, Inc. | LINK WILLIAM J PHD | Dir | J - Other | $0.00 | -245.7K | 862.3K | -22% | $0 |
| D | 2021-08-05 | 2021-08-03 | RXST | RxSight, Inc. | LINK WILLIAM J PHD | Dir, 10% | P - Purchase | $16.00 | +31.2K | 37.1K | +533% | +$500.0K |
| DI | 2021-08-05 | 2021-08-03 | RXST | RxSight, Inc. | LINK WILLIAM J PHD | Dir, 10% | C - Cnv Deriv | $0.00 | +2.02M | 2.02M | New | $0 |
| 2021-08-02 | 2021-07-30 | RXST | RxSight, Inc. | LINK WILLIAM J PHD | Dir | A - Grant | $0.00 | +5,859 | 5,859 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations